Are Options Traders Betting on a Big Move in Adverum (ADVM) Stock?Zacks Investment Research • 05/18/21
The Sonic Fund II, L.P. Comments on Preliminary Voting Results of Adverum Annual MeetingBusiness Wire • 05/12/21
Adverum Stockholders Re-Elect All Adverum Director Nominees at 2021 Annual MeetingGlobeNewsWire • 05/12/21
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Adverum Biotechnologies, Inc. - ADVMPRNewsWire • 05/11/21
The Sonic Fund II, L.P. Reminds Adverum Stockholders to Vote for Its Three Independent Director Nominees at May 12 Annual MeetingBusiness Wire • 05/10/21
Adverum Biotechnologies (ADVM) Reports Q1 Loss, Tops Revenue EstimatesZacks Investment Research • 05/06/21
Glass Lewis Joins ISS In Recommending Adverum Shareholders Vote for All Three Independent Sonic Director NomineesBusiness Wire • 05/06/21
ISS Recommends Adverum Stockholders Vote to Elect Sonic's Three Independent, Highly Qualified NomineesBusiness Wire • 05/04/21
Adverum's Wet AMD Gene Therapy Shows Long Term Benefit In Treatment-Experienced PatientsBenzinga • 05/03/21
Adverum Biotechnologies Presents Long-term Data through March 10, 2021 from the OPTIC Trial of ADVM-022 Intravitreal Gene Therapy in Treatment-experienced Wet AMD Patients at ARVO 2021GlobeNewsWire • 05/01/21
The Sonic Fund II, L.P. Comments on Adverum Biotechnologies Update Regarding INFINITY Phase 2 Trial of ADVM-022Business Wire • 04/29/21
Adverum Biotechnologies Provides Update on the INFINITY Trial Evaluating ADVM-022 in Patients with Diabetic Macular EdemaGlobeNewsWire • 04/28/21